Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Dual-Drug DES and New "Limus" Debut to Mixed Reviews
Link ID 4763
Title Dual-Drug DES and New "Limus" Debut to Mixed Reviews
Url http://www.medscape.com/viewarticle/572822?src=rss
Description There was applause for the Conor stent and its tiny reservoirs filled with two drugs, but one of the drugs, pimecrolimus, bombed in the small randomized trial. Investigators lowered the curtain early. Heartwire
Category Articles > Cardiology
Keywords
Date Apr 11, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Chronic Kidney Disease May Independently Predict MI, Stroke, Death
  An analysis of KEEP and NHANES showed that CKD independently predicted myocardial infarction, stroke, and death among participants. Medscape Medical News
Category:   Articles > Cardiology


2. New Imatinib Formulation Cuts Cardiac Toxicity
  Researchers have gone back to the drawing board with the blockbuster drug and are working to eliminate its adverse effects. Medscape Medical News
Category:   Articles > Cardiology


3. Adding Tirofiban in Aspirin/Clopidogrel Nonresponders Cuts Periprocedural MI
  A new study in low-risk, elective-PCI patients who were also nonresponsive to aspirin and/or clopidogrel shows that adding tirofiban during PCI can cut MI rates by more than 40%, as compared with patients given a placebo infusion. Heartwire
Category:   Articles > Cardiology


4. ACC 2008: The Future of Managing Dyslipidemia
  ACC.08: Statins may be wonder drugs, but they still leave a significant percentage of patients at risk -- so the latest clinical trial and research results will be good news for treating dyslipidemia. Medscape Cardiology
Category:   Articles > Cardiology


5. Ten Years Later, UKPDS Shows Intensive Glucose Lowering, but Not Tight BP Control, Reduces MI, All-C
  Monitoring from a landmark study indicates that intensive glucose lowering has significant effects on major diabetes endpoints and on the risks for myocardial infarction and all-cause mortality. Medscape Medical News
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS